Lifecore Biomedical Inc
NASDAQ:LFCR
Lifecore Biomedical Inc
Other Long-Term Assets
Lifecore Biomedical Inc
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
Other Long-Term Assets
$2.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
|
|
Hershey Co
NYSE:HSY
|
Other Long-Term Assets
$1.1B
|
CAGR 3-Years
78%
|
CAGR 5-Years
47%
|
CAGR 10-Years
24%
|
|
|
General Mills Inc
NYSE:GIS
|
Other Long-Term Assets
$1.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
|
Kellogg Co
NYSE:K
|
Other Long-Term Assets
$1.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
|
Kraft Heinz Co
NASDAQ:KHC
|
Other Long-Term Assets
$4.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Mondelez International Inc
NASDAQ:MDLZ
|
Other Long-Term Assets
$2.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
What is Lifecore Biomedical Inc's Other Long-Term Assets?
Other Long-Term Assets
2.6m
USD
Based on the financial report for Nov 24, 2024, Lifecore Biomedical Inc's Other Long-Term Assets amounts to 2.6m USD.
What is Lifecore Biomedical Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
4%
Over the last year, the Other Long-Term Assets growth was -37%. The average annual Other Long-Term Assets growth rates for Lifecore Biomedical Inc have been -7% over the past three years , and 4% over the past ten years .
You don't have any saved screeners yet